History And Newer Management Strategies In Acoustic Neuroma Management | 12378
Otolaryngology: Open Access
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Vesitbular schwannomas are the most common CPA tumor representing 6%-10% of intracranial
neoplasm. Incidence is 10 per million per year in the US. NF2 represents about 5% of these
CPA tumors. Among these cases 10% will present with normal hearing, and 90% will present with
unilateral hearing loss and tinnitus. ABR is a noninvasive test for acoustic neuroma with a fairly high
false potential rate. However, MRI is still the gold standard in diagnosis of tumors 2mm in size or larger.
Three management strategies: observation, radiation, and surgery are the options for patients and each
will be discussed on the basis of management of more than 1500 cases seen over a thirty year period.
We will focus this talk on recent conservative trends in management of the acoustic neuroma patient
in the past decade.
Richard J. Wiet, M.D., F.A.C.S., is Professor of Clinical Otolaryngology and Neurosurgery at Northwestern Univer
sity and Senior Partner, Ear Institute of Chicago, LLC. Wiet has been consistently listed in Chicago?s Magazine?s ?Top
Doctors? for years. In 2011, Dr. Wiet was presented with the Professional Excellence Award from the Acoustic Neuroma
Association. Dr. Wiet?s 30 years in the field of neurotology is reflected in a textbook he edited, released in February, 2006,
entitled ?Ear Surgery-Minimizing Risks and Complications,? published by
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals